Literature DB >> 26080698

Clinically applicable magnetic-labeling of natural killer cells for MRI of transcatheter delivery to liver tumors: preclinical validation for clinical translation.

Kangan Li1,2,3, Andrew C Gordon2, Linfeng Zheng1,2,3, Weiguo Li2, Yang Guo2, Jing Sun2, Guixiang Zhang1, Guohong Han4, Andrew C Larson2,3, Zhuoli Zhang2,3.   

Abstract

AIM: To test the hypothesis that MRI can monitor intraportal vein (IPV) transcatheter delivery of clinically applicable heparin-protamine-ferumoxytol (HPF) nanocomplex-labeled natural killer (NK) cells to liver tumor. MATERIALS &
METHODS: Liver tumor rat models underwent catheterization for IPV infusion of HPF-labeled NK cells (NK-92MI cell line). MRI measurements within tumor and adjacent liver tissues were compared pre- and post-NK cell infusion. Histology studies were used to identify NK cells in the target tumors.
RESULTS: For first time, we demonstrated that MRI tracks HPF-labeled NK cells migration within liver following IPV delivery.
CONCLUSION: IPV transcatheter infusion permitted selective delivery of NK cells to liver tissues and MRI allowed tracking NK cell biodistributions within the tumors.

Entities:  

Keywords:  MRI; liver tumor; natural killer cell; portal vein; rat; transcatheter delivery

Mesh:

Substances:

Year:  2015        PMID: 26080698      PMCID: PMC4520233          DOI: 10.2217/nnm.15.24

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  42 in total

1.  Monitoring of a new approach of immunotherapy with allogenic (111)In-labelled NK cells in patients with renal cell carcinoma.

Authors:  Birgit Meller; Christoph Frohn; Jörg-Matthias Brand; Isabel Lauer; Lutz F Schelper; Katharina von Hof; Holger Kirchner; Eckart Richter; Manfred Baehre
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12-19       Impact factor: 9.236

Review 2.  Cell tracking with optical imaging.

Authors:  Elizabeth J Sutton; Tobias D Henning; Bernd J Pichler; Christoph Bremer; Heike E Daldrup-Link
Journal:  Eur Radiol       Date:  2008-05-28       Impact factor: 5.315

3.  Activated NKT cells and NK cells render T cells resistant to myeloid-derived suppressor cells and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transgenic mouse.

Authors:  Maciej Kmieciak; Debasmita Basu; Kyle K Payne; Amir Toor; Adly Yacoub; Xiang-Yang Wang; Lisa Smith; Harry D Bear; Masoud H Manjili
Journal:  J Immunol       Date:  2011-06-13       Impact factor: 5.422

Review 4.  Variations in feeding arteries of hepatocellular carcinoma located in the left hepatic lobe.

Authors:  Shiro Miyayama; Masashi Yamashiro; Yoshihiro Shibata; Masahiro Hashimoto; Miki Yoshida; Kazunobu Tsuji; Fumihito Toshima; Osamu Matsui
Journal:  Jpn J Radiol       Date:  2012-04-03       Impact factor: 2.374

Review 5.  Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92.

Authors:  T Tonn; S Becker; R Esser; D Schwabe; E Seifried
Journal:  J Hematother Stem Cell Res       Date:  2001-08

6.  Compatibility of superparamagnetic iron oxide nanoparticle labeling for ¹H MRI cell tracking with ³¹P MRS for bioenergetic measurements.

Authors:  Zhuoli Zhang; Brynne Hancock; Stephanie Leen; Sharan Ramaswamy; Steven J Sollott; Kenneth R Boheler; Magdalena Juhaszova; Edward G Lakatta; Richard G Spencer; Kenneth W Fishbein
Journal:  NMR Biomed       Date:  2010-09-20       Impact factor: 4.044

7.  Distinct roles for the NK cell-activating receptors in mediating interactions with dendritic cells and tumor cells.

Authors:  Lu-En Wai; Jordan A Garcia; Olivia M Martinez; Sheri M Krams
Journal:  J Immunol       Date:  2010-11-24       Impact factor: 5.422

8.  Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor.

Authors:  Tolga Sutlu; Birgitta Stellan; Mari Gilljam; Hernan Concha Quezada; Hareth Nahi; Gösta Gahrton; Evren Alici
Journal:  Cytotherapy       Date:  2010-08-26       Impact factor: 5.414

Review 9.  Monitoring of natural killer cell immunotherapy using noninvasive imaging modalities.

Authors:  Priyanka Jha; Daniel Golovko; Sukhmine Bains; Daniel Hostetter; Reinhard Meier; Michael F Wendland; Heike E Daldrup-Link
Journal:  Cancer Res       Date:  2010-07-14       Impact factor: 12.701

10.  Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging.

Authors:  Matthias Edinger; Yu-An Cao; Michael R Verneris; Michael H Bachmann; Christopher H Contag; Robert S Negrin
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113

View more
  9 in total

Review 1.  Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational considerations.

Authors:  Ankit Shah; Marina A Dobrovolskaia
Journal:  Nanomedicine       Date:  2018-02-02       Impact factor: 5.307

2.  18F-FDG PET Biomarkers Help Detect Early Metabolic Response to Irreversible Electroporation and Predict Therapeutic Outcomes in a Rat Liver Tumor Model.

Authors:  Xifu Wang; Zhanliang Su; Tianchu Lyu; Matteo Figini; Daniel Procissi; Junjie Shangguan; Chong Sun; Bin Wang; Na Shang; Shanzhi Gu; Quanhong Ma; Andrew C Gordon; Kai Lin; Jian Wang; Robert J Lewandowski; Riad Salem; Vahid Yaghmai; Andrew C Larson; Zhuoli Zhang
Journal:  Radiology       Date:  2017-12-12       Impact factor: 11.105

3.  Physicochemical characterization of ferumoxytol, heparin and protamine nanocomplexes for improved magnetic labeling of stem cells.

Authors:  L Henry Bryant; Saejeong J Kim; Matthew Hobson; Blerta Milo; Zsofia I Kovacs; Neekita Jikaria; Bobbi K Lewis; Maria A Aronova; Alioscka A Sousa; Guofeng Zhang; Richard D Leapman; Joseph A Frank
Journal:  Nanomedicine       Date:  2016-08-09       Impact factor: 5.307

4.  HSP70/IL-2 Treated NK Cells Effectively Cross the Blood Brain Barrier and Target Tumor Cells in a Rat Model of Induced Glioblastoma Multiforme (GBM).

Authors:  Farzaneh Sharifzad; Soura Mardpour; Saeid Mardpour; Esmaeil Fakharian; Adeleh Taghikhani; Amirhossein Sharifzad; Sahar Kiani; Yasaman Heydarian; Marek J Łos; Zahra Azizi; Saeid Ghavami; Amir Ali Hamidieh; Marzieh Ebrahimi
Journal:  Int J Mol Sci       Date:  2020-03-25       Impact factor: 5.923

Review 5.  Options for imaging cellular therapeutics in vivo: a multi-stakeholder perspective.

Authors:  Brooke M Helfer; Vladimir Ponomarev; P Stephen Patrick; Philip J Blower; Alexandra Feitel; Gilbert O Fruhwirth; Shawna Jackman; Lucilia Pereira Mouriès; Margriet V D Z Park; Mangala Srinivas; Daniel J Stuckey; Mya S Thu; Tineke van den Hoorn; Carla A Herberts; William D Shingleton
Journal:  Cytotherapy       Date:  2021-04-06       Impact factor: 6.196

Review 6.  Immune cell labelling and tracking: implications for adoptive cell transfer therapies.

Authors:  Filippo Galli; Michela Varani; Chiara Lauri; Guido Gentiloni Silveri; Livia Onofrio; Alberto Signore
Journal:  EJNMMI Radiopharm Chem       Date:  2021-02-03

7.  A dual-modal PET/near infrared fluorescent nanotag for long-term immune cell tracking.

Authors:  Stefan Harmsen; Emin Ilker Medine; Maxim Moroz; Fuad Nurili; Jose Lobo; Yiyu Dong; Mezruh Turkekul; Naga Vara Kishore Pillarsetty; Richard Ting; Vladimir Ponomarev; Oguz Akin; Omer Aras
Journal:  Biomaterials       Date:  2020-12-23       Impact factor: 12.479

Review 8.  Magnetic Nanostructures as Emerging Therapeutic Tools to Boost Anti-Tumour Immunity.

Authors:  Stefano Persano; Pradip Das; Teresa Pellegrino
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

Review 9.  Iron oxide nanoparticles for immune cell labeling and cancer immunotherapy.

Authors:  Seokhwan Chung; Richard A Revia; Miqin Zhang
Journal:  Nanoscale Horiz       Date:  2021-07-20       Impact factor: 11.684

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.